Molecular genetics of small cell lung carcinoma

Seminars in Oncology

Volumn 28, Issue 2 SUPPL. 4, 2001, Pages 3-13

  Wistuba, Ignacio I ^a,b,c   Gazdar, Adi F ^a,b,c   Minna, John D ^a,b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOMBESIN; GASTRIN RELEASING PEPTIDE; MICROSATELLITE DNA; PROTEIN P16; PROTEIN P53; REGULATOR PROTEIN;

ALLELISM; CANCER RISK; CARCINOGENESIS; CIGARETTE SMOKING; GENE LOCUS; GENE MUTATION; GENE OVEREXPRESSION; GENETIC POLYMORPHISM; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; METHYLATION; MOLECULAR GENETICS; ONCOGENE MYC; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TUMOR SUPPRESSOR GENE;

EID: 0034910622     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonc.2001.25738     Document Type: Review

References (62)

1. Global cancer statistics
2. Molecular genetic characterization of neuroendocrine lung cancer cell lines
3. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid
4. Genetic changes in the spectrum of neuroendocrine lung tumors
5. Identification of MEN 1 gene mutations in sporadic carcinoid tumors of the lung
6. Precursors to pulmonary neoplasia
7. Involvement of signal transduction pathways in lung cancer biology
8. The biology of lung cancer
9. Bombesin receptor structure and expression in human lung carcinoma cell lines
10. Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor
11. Progress in understanding the molecular pathogenesis of human lung cancer
12. Multiple mechanisms for transcriptional regulation of the myc gene family in small-cell lung cancer
13. MYC family DNA amplification in 126 tumor cell lines from patients with small cell lung cancer
14. Expression of bcl-2-protein in small cell lung cancer
15. bcl-2 protein in non-small-cell lung carcinoma
16. Survival in small cell lung carcinoma is independent of Bcl-2 expression
17. Bax suppresses tumorigenesis and stimulates apoptosis in vivo
18. Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors
19. p53 tumor suppressor gene: From the basic research laboratory to the clinic - An abridged historical perspective
20. DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies
21. Molecular changes in the bronchial epithelium of patients with small cell lung cancer
22. p53: A frequent target for genetic abnormalities in lung cancer
23. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53
24. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC
25. Differential retinoblastoma protein expression in neuroendocrine tumors of the lung. Potential diagnostic implications
26. Differential expression of the retinoblastoma gene family members pRb/p105, p107, and pRb2/pl30 in lung cancer
27. Loss of the retinoblastoma protein-related p130 protein in small cell lung carcinoma
28. The RB2/p130 gene: The latest weapon in the war against lung cancer?
29. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer
30. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN
31. Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types
32. Mutation analysis of the PTEN/MMAC1 gene in lung cancer
33. The breast cancer gene product TSG101: A regulator of ubiquitination?
34. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours
35. Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer
36. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints
37. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: Identification and evaluation of the resident candidate tumor suppressor genes
38. RASFF1A in the 3p21.3 homozygous deletion region: Epigenetic inactivation in lung and breast cancer and suppression of the malignant phenotype
39. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3
40. The FHIT gene at 3p14.2 is abnormal in lung cancer
41. FHIT and FRA3B allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations
42. Abnormal FHIT transcripts found in both lung cancer and normal lung tissue
43. Homozygous deletions at 3p12 in breast and lung cancer
44. Deletions of chromosome 4 at multiple sites are frequent in malignant mesothelioma and small cell lung carcinoma
45. Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancer
46. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell and non-small cell lung cancer, and loci clustering
47. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients
48. Microsatellite instability: Marker of a mutator phenotype in cancer
49. Alterations in DNA methylation: A fundamental aspect of neoplasia
50. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns
51. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients
52. Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer
53. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis
54. Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer
55. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3
56. Promoter methylation and silencing of the retinoic acid receptor beta gene in lung carcinomas
57. Strategies for chemoprevention study of premalignancy and second primary tumors in the head and neck
58. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma
59. Molecular damage in the bronchial epithelium of current and former smokers
60. Clonal genetic alterations in the lungs of current and former smokers